Since 1967, Fermilab has worked to answer these and other fundamental questions and enhance our understanding of everything we see around us. As the United States' premier particle physics laboratory, we work on the world's most advanced particle accelerators and dig down to the smallest building blocks of matter.
So, survival rate and life expectancy for stage 4 prostate cancer cannot be favorable. âº The five-year relative survival rate for prostate cancer that has spread to distant organs is 28%. This means about 28% of the patients with stage 4 prostate cancer will live for five years.
Cancer of the larynx is often grouped into early (Stage I), intermediate (Stage II) or advanced (Stages III & IV) disease groups. Early cancers are remarkably curable with five-year survival or cure rates of 80-95% compared to advanced stages that have five-year survival rates of 25-50%.